Neuromuscular Blocking Agents and Reversal Agents Among Hospitalized Children: A Cerner Database Study:

Background: Sugammadex (Bridion) was approved by the US Food and Drug Administration (FDA) in December 2015 for the reversal of neuromuscular block (NMB) induced by rocuronium and vecuronium bromid...